Baldwin Insurance Group, Inc.
BWINBusiness Summary
The Baldwin Insurance Group, Inc. (Baldwin) operates as an independent insurance distribution firm, providing expertise and insights in risk management, insurance, and employee benefits. The company's core products include commercial property and casualty insurance, employee benefits insurance, personal lines insurance, wealth management and retirement services, and Medicare. Baldwin competes on reputation, client service, industry insights, product offerings, and tailoring services to client needs. The insurance brokerage industry, while experiencing consolidation, remains highly fragmented, which Baldwin views as an opportunity for further acquisitions. The company serves over three million clients across the United States and internationally, with approximately 5,000 colleagues and 125 offices in 24 states 7.
Baldwin's business model is centered on generating revenue through commissions and fees by facilitating arrangements between insurance/reinsurance company partners and clients. Revenue streams include core commissions, profit-sharing commissions, consulting and service fees, policy and installment fees, and earned premiums from its Captive business. The company also earns investment income. A significant portion of its core commissions and fees, approximately 17% 28, is derived from two insurance company partners in 2025. The company's growth strategy involves both organic growth, driven by winning new business, expanding insurance solutions, and increasing economic capture, and inorganic growth through strategic partnerships 9.
The company's operations are divided into three reportable segments: Insurance Advisory Solutions (IAS), Underwriting, Capacity & Technology Solutions (UCTS), and Mainstreet Insurance Solutions (MIS). IAS focuses on commercial risk management, employee benefits, and private risk management solutions for businesses and high-net-worth individuals. UCTS comprises MSI (a Managing General Agent platform for proprietary, technology-enabled insurance products), a Capacity Solutions group (including reinsurance brokerage, reinsurance MGA, and captive management), and the Captive business. MIS offers personal, commercial, and life and health solutions to individuals and businesses, with a focus on sheltered distribution channels and government assistance programs like Medicare 10.
In the fiscal year ended December 31, 2025, IAS generated total revenues of $727.324 million 63, an increase of 2% year-over-year. Core commissions and fees for IAS were $661.590 million 63, growing by $20.304 million 63 or 3% 63, primarily due to organic growth. Profit-sharing and other income for IAS decreased by $3.487 million 63 to $61.384 million 63, a 5% decline 63. Operating income for IAS was $56.300 million 63, a 20% increase 63 from the prior year.
UCTS reported total revenues of $549.452 million 65 for the year ended December 31, 2025, representing a 16% increase 65 year-over-year. Core commissions and fees for UCTS grew by $71.400 million 65, or 16% 65, to $527.245 million 65, driven by MSI outperformance ($41.2 million 66), the introduction of the Captive ($22.6 million 66), and momentum in the Capacity Solutions group ($13.9 million 66). Profit-sharing and other income for UCTS increased by $4.313 million 65, or 33% 65, to $17.345 million 65. UCTS operating income increased by 46% 65 to $72.221 million 65.
MIS generated total revenues of $297.747 million 67 in 2025, a 6% increase 67 from the previous year. Core commissions and fees for MIS increased by $14.458 million 67, or 6% 67, to $265.283 million 67. This growth was primarily attributed to the recently acquired Hippo's Homebuilder Distribution Network ($15.8 million 68), the national mortgage and real estate channel ($2.6 million 68), and the Westwood business ($1.5 million 68), partially offset by a decrease in the Medicare business ($5.0 million 68). Profit-sharing and other income for MIS increased by $1.842 million 67, or 6% 67, to $32.265 million 67. Operating income for MIS decreased by 15% 67 to $35.806 million 67.
For the fiscal year ended December 31, 2025, Baldwin reported total revenues of $1.504 billion 11, an 8% increase 11 from $1.389 billion 11 in 2024. Core commissions and fees grew by $114.265 million 12, or 9% 12, to $1.383 billion 12. Profit-sharing and other income increased by $2.299 million 12, or 2% 12, to $110.625 million 12. Total operating expenses for 2025 were $1.430 billion 12, an 8% increase 12 from $1.328 billion 12 in 2024. This resulted in an operating income of $73.936 million 12, up 22% 12 from $60.648 million 12 in 2024. The company reported a net loss of $54.154 million 13, or a $0.50 loss per fully diluted share 13, compared to a net loss of $41.081 million 13, or a $0.39 loss per fully diluted share 13, in 2024. Adjusted EBITDA for 2025 was $341.472 million 14, an increase of $29.0 million 14 year-over-year, with an adjusted EBITDA margin of 22.7% 14, a 20 basis point expansion 14. Adjusted net income was $198.942 million 15, up $22.0 million 15 year-over-year, and adjusted diluted EPS was $1.67 15, an 11% increase 15 from $1.50 15 in 2024. Organic revenue for 2025 was $1.470 billion 16, with organic revenue growth of $100.049 million 16, or 7% 16.
Year-over-year, total revenues increased by $115.847 million 12, or 8% 12. Colleague compensation and benefits increased by $15.312 million 12, or 2% 12, to $777.531 million 12. Outside commissions increased by $9.882 million 12, or 4% 12, to $279.711 million 12. Other operating expenses rose by $47.916 million 12, or 25% 12, to $240.282 million 12, driven by higher incurred losses and loss adjustment expense of $19.1 million 19 related to the Captive business, professional fees of $14.0 million 19, technology and software-related costs of $4.4 million 19, advertising and marketing of $3.6 million 19, legal settlement expense of $2.1 million 19, and licenses and taxes of $2.1 million 19. Amortization expense increased by $18.586 million 12, or 18% 12, to $121.316 million 12. Interest expense, net, decreased by $2.216 million 12, or 2% 12, to $121.428 million 12. The company reported a loss on extinguishment and modification of debt of $6.226 million 12 in 2025, compared to $15.113 million 12 in 2024.
During 2025, Baldwin launched two new middle-market oriented commercial lines products within its MGA product suite and maintains a pipeline of new programs across personal, commercial, and professional lines, with several slated for launch in 2026 10. In January 2025, the company received final approval and a Certificate of Authority from the Texas Department of Insurance to form a Texas-domiciled reciprocal insurance exchange, which began writing business late in the second quarter of 2025 10. The third-party led capitalization of the Reciprocal closed and funded in full on May 6, 2025 10. Effective April 1, 2025, Baldwin partnered with MultiStrat Group, a Bermuda-based reinsurance underwriting platform, to source alternative reinsurance capital 102. Effective July 1, 2025, the company acquired Hippo's Homebuilder Distribution Network, enhancing its ability to deliver property and casualty insurance solutions to homebuilder clients 103. The Wholesale Business, operating within UCTS, was sold on March 1, 2024, for proceeds of approximately $58.9 million 105, resulting in a pre-tax gain of $35.1 million 105.
Business Outlook
Management anticipates interest expense to grow in the near term on a year-over-year basis due to higher borrowings under the JPM Credit Facility to fund partnership opportunities and the settlement of deferred payment obligations, although this will be slightly offset by lower expected average interest rates 55. The company expects rate softness in the insurance market to continue into 2026, particularly in commercial property lines 64.
A major growth area for Baldwin is its partnership strategy, which has contributed meaningful inorganic growth and is expected to remain active and opportunistic 9. On January 1, 2026, the company completed a partnership with CAC Group, a nationally recognized specialty and middle-market insurance brokerage firm 55. This transaction involved aggregate consideration of $438.0 million in cash and 23,200,000 shares of Class A common stock 55. The purchase consideration also includes a deferred payment of $70.0 million in cash, payable upon the fourth anniversary of the closing date, and a contingent earnout of up to $250.0 million based on certain post-closing revenue-focused performance measures 55. This partnership is expected to significantly expand the specialty capabilities of the IAS operating group and strengthen its specialty product lines and data and analytics platform 55.
Another key growth area is the continued investment in existing businesses to drive organic growth, primarily through winning new business, offering a broader array of insurance solutions in an expanded geographic footprint, and capturing a larger portion of insurance sale economics 9. The company has invested heavily in sales leadership infrastructure, recruitment of sales and technology talent, and solutions to better deliver insurance insights to risk advisors and clients 9. The MSI platform continues to deliver proprietary and technology-enabled insurance solutions, providing speed, ease of use, and certainty of execution to risk advisors and external distribution partners, while enhancing Baldwin's share of economics 9. In 2025, the company launched two new middle-market oriented commercial lines products and maintains a pipeline of new programs across personal, commercial, and professional lines, with several slated to launch in 2026 10.
Operationally, Baldwin expects a general rise in colleague compensation and benefits expense commensurate with expected revenue growth, as compensation arrangements with colleagues and risk advisors include significant bonus or commission components tied to operating results 58. The company also operates in competitive markets for human capital and needs to maintain competitive compensation levels as it expands geographically and creates new products and services 58. The company is implementing a $3B/30 Catalyst Program, designed to accelerate the infusion of automation, business process optimization, and artificial intelligence to transform and elevate its workforce and unlock new avenues for growth 61.
The company's primary liquidity needs for the foreseeable future include cash to provide capital for organic growth and future partnerships, pay operating expenses (including cash compensation and public company expenses), make payments under the Tax Receivable Agreement, pay interest and principal on borrowings under the JPM Credit Facility and Senior Secured Notes, pay contingent earnout liabilities, pay income taxes, and fund potential investments in third-party businesses 69. The Board of Directors has authorized the repurchase of up to $250 million of outstanding common stock 70.
Management has flagged several structural headwinds and execution risks. Organic growth in IAS was pressured by 380 bps of headwind in underlying rate and exposure during 2025, attributable to softening insurance rates, particularly in the property line of business, construction project work weakness, and overall lower economic activity 64. MIS core commissions and fees growth was negatively impacted by headwinds in the health business and continued pressure in the legacy Mainstreet business 68. Effective May 1, 2025, MIS is receiving reduced commissions from QBE Insurance Corporation and its affiliates on a portion of its builder-sourced homeowners book of business being migrated to the Reciprocal, a temporary headwind expected to persist through the first half of 2026 before reversing into a tailwind 68.
Risk Factors
Baldwin faces material risks including insufficient cash flows to service indebtedness, pay contingent earnout liabilities, or finance working capital needs, potentially forcing asset sales or operational curtailment. The company has approximately $1.7 billion 18 in total consolidated debt outstanding as of December 31, 2025, with debt servicing costs of $279.1 million 18 in 2025, including $163.2 million 18 in principal repayments and $115.3 million 18 in interest payments. An additional $600.0 million 18 of incremental term B loans were incurred on January 2, 2026, increasing indebtedness. Macroeconomic conditions, such as inflation and rising interest rates, can reduce demand for services, increase operating expenses (including compensation and rent escalations in leases that expire through August 2035 71), and impact profitability. Volatility or declines in insurance premiums and commission rates, which are set by insurance company partners, can seriously undermine profitability, especially given that contingent commissions have generally ranged from 6.5% to 8.5% 21 of total core commissions and fees over the last two years. The company's business is highly concentrated in the Southeastern U.S., with two insurance company partners accounting for approximately 17% 28 of total core commissions and fees in 2025, making it vulnerable to regional economic downturns, natural disasters, or regulatory changes. The inability to effectively apply technology, including artificial intelligence, or to retain and hire qualified colleagues, including executive officers, could negatively impact reputation and business generation. Partnerships, while important for growth, carry risks of unsuccessful integration, unforeseen liabilities, and failure to achieve anticipated benefits. The company also faces risks of impairment of goodwill, which stood at $1.5 billion 27 as of December 31, 2025, representing 39% 27 of total assets. Regulatory non-compliance, E&O claims, and cybersecurity incidents pose significant legal and financial liabilities, with potential for fines, penalties, and reputational harm. The marketing and sale of Medicare plans are subject to numerous, complex, and frequently changing laws and regulations, with non-compliance potentially leading to termination of insurance company partner relationships or loss of commissions.
Management Priorities
Management's message to shareholders emphasizes a strategy centered on reinvesting retained earnings into future growth, aiming to produce sustainable results for all stakeholders, including clients, colleagues, insurance company partners, communities, and stockholders. The company believes this approach will lead to increased value for stockholders through revenue growth and margin accretion over time, generating significant adjusted free cash flow. Management is pursuing a two-pronged growth approach: meaningful investment in existing businesses to drive organic growth and inorganic growth through strategic partnerships. They highlight continued investment in sales leadership, recruitment of talent, and technology solutions, including the MSI platform, to enhance service delivery and capture a greater share of insurance economics. Management explicitly states that organic growth will be driven by winning new business, expanding insurance solutions, and increasing geographic footprint. The company's partnership strategy is described as active and opportunistic, focusing on high-quality, fast-growing independent firms, with a differentiated value proposition that includes retained business decision-making autonomy and leadership opportunities for new partners. Management notes the completion of 37 partnerships since the beginning of 2020, acquiring $909.0 million 9 of revenue, including nine "Top 100" firms. They also highlight the recent partnership with CAC Group on January 1, 2026, which involved $438.0 million 55 in cash and 23,200,000 shares 55 of Class A common stock, with a deferred payment of $70.0 million 55 and a contingent earnout of up to $250.0 million 55. Management expects interest expense to grow in the near term due to higher borrowings under the JPM Credit Facility to fund partnership opportunities and deferred payment obligations, offset slightly by lower expected average interest rates 55.
View Source Annual Report on SEC.gov ↗
References
- [1] Item 1, Business
- [2] Item 1, Business
- [3] Item 1, Business
- [4] Item 1, Business
- [5] Item 1, Business
- [6] Item 1, Business
- [7] Item 1, Business
- [8] Item 1, Business
- [9] Item 1, Business Strategy
- [10] Item 1, Operating Groups
- [11] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [12] Item 7, MD&A — Results of Operations for the Years Ended December 31, 2025 and 2024
- [13] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [14] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [15] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [16] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [17] Item 7, MD&A — Colleague Compensation and Benefits
- [18] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [19] Item 7, MD&A — Other Operating Expenses
- [20] Item 7, MD&A — Interest Expense, Net
- [21] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [22] Item 7, MD&A — Recent Developments
- [23] Item 7, MD&A — Recent Developments
- [24] Item 7, MD&A — Recent Developments
- [25] Item 7, MD&A — Recent Developments
- [26] Item 7, MD&A — Recent Developments
- [27] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [28] Item 1, Clients and Insurers
- [29] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [30] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [31] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [32] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [33] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [34] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [35] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [36] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [37] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [38] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [39] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [40] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [41] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [42] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [43] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [44] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [45] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [46] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [47] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [48] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [49] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [50] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [51] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [52] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [53] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [54] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
- [55] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [56] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [57] Item 7, MD&A — Executive Summary of 2025 Financial Results
- [58] Item 7, MD&A — Colleague Compensation and Benefits
- [59] Item 7, MD&A — Colleague Compensation and Benefits
- [60] Item 7, MD&A — Colleague Compensation and Benefits
- [61] Item 7, MD&A — Adjusted EBITDA and Adjusted EBITDA Margin
- [62] Item 7, MD&A — Liquidity and Capital Resources
- [63] Item 7, MD&A — Insurance Advisory Solutions Operating Group Results
- [64] Item 7, MD&A — Insurance Advisory Solutions Operating Group Results
- [65] Item 7, MD&A — Underwriting, Capacity & Technology Solutions Operating Group Results
- [66] Item 7, MD&A — Underwriting, Capacity & Technology Solutions Operating Group Results
- [67] Item 7, MD&A — Mainstreet Insurance Solutions Operating Group Results
- [68] Item 7, MD&A — Mainstreet Insurance Solutions Operating Group Results
- [69] Item 7, MD&A — Liquidity and Capital Resources
- [70] Item 7, MD&A — Liquidity and Capital Resources
- [71] Item 7, MD&A — Contractual Obligations and Commitments
- [72] Item 7, MD&A — Contractual Obligations and Commitments
- [73] Item 7, MD&A — Contractual Obligations and Commitments
- [74] Item 7, MD&A — Contractual Obligations and Commitments
- [75] Item 7, MD&A — Contractual Obligations and Commitments
- [76] Item 7, MD&A — Contractual Obligations and Commitments
- [77] Item 7, MD&A — Contractual Obligations and Commitments
- [78] Item 7, MD&A — Contractual Obligations and Commitments
- [79] Item 7, MD&A — Contractual Obligations and Commitments
- [80] Item 7, MD&A — Contractual Obligations and Commitments
- [81] Item 7, MD&A — Contractual Obligations and Commitments
- [82] Item 7, MD&A — Contractual Obligations and Commitments
- [83] Item 7, MD&A — Contractual Obligations and Commitments
- [84] Item 7, MD&A — Contractual Obligations and Commitments
- [85] Item 7, MD&A — Contractual Obligations and Commitments
- [86] Item 7, MD&A — Contractual Obligations and Commitments
- [87] Item 7, MD&A — Contractual Obligations and Commitments
- [88] Item 7, MD&A — Contractual Obligations and Commitments
- [89] Item 7, MD&A — Contractual Obligations and Commitments
- [90] Item 7, MD&A — Contractual Obligations and Commitments
- [91] Item 7, MD&A — Contractual Obligations and Commitments
- [92] Item 7, MD&A — Contractual Obligations and Commitments
- [93] Item 7, MD&A — Contractual Obligations and Commitments
- [94] Item 7, MD&A — Contractual Obligations and Commitments
- [95] Item 7, MD&A — Contractual Obligations and Commitments
- [96] Item 7, MD&A — Contractual Obligations and Commitments
- [97] Item 7, MD&A — Contractual Obligations and Commitments
- [98] Item 7, MD&A — Contractual Obligations and Commitments
- [99] Item 7, MD&A — Contractual Obligations and Commitments
- [100] Item 7, MD&A — Contractual Obligations and Commitments
- [101] Item 7, MD&A — Contractual Obligations and Commitments
- [102] Item 3, Business Combinations
- [103] Item 3, Business Combinations
- [104] Item 4, Business Divestitures
- [105] Item 4, Business Divestitures
Analysis on 5/20/2026